HMW Innovations

About The Fund

HMW Innovations, established in 2002 and based in Munich, Germany, is a venture capital firm that specializes in seed, early-stage, and later-stage investments. Their focus is on investing in innovative technology companies that are not yet publicly traded and have the potential to disrupt their respective industries. They target various sectors, including energy efficiency, biotechnology, medical technology, new material, and information technology. Beyond these areas, HMW Innovations also shows interest in Software (Web Marketplace SaaS, etc.), BioTech, Hardware (& Manufacturing), HealthTech (& Fitness), Robotics, Real Estate (& Construction), and Life Science. The firm offers a unique proposition for private investors through their MIG Fonds, which are designed to support young, innovative technology companies exploring new paths in growing markets. HMW Innovations prides itself on its forward-looking and strategic approach, as evidenced by their recognition as a winner of the 'Deutscher Fondspreis 2024' in the category 'Service-Qualität der Sachwertinvestment-Anbieter,' highlighting their outstanding achievements in distribution support and product reliability. The firm has a standardized investment range with a minimum and maximum investment of €2,880,000, showing a clear commitment to the scale and growth potential of their investees. They are involved in various initiatives and successes, as demonstrated by their portfolio companies' advancements in areas such as quantum solutions for portfolio optimization, the development of the world's most powerful exoskeleton, and innovation in the management of Type 2 Diabetes. Their investment thesis is centered around identifying promising technology ventures and providing them with the capital and support needed to realize their full potential and achieve significant growth.